Ironwood Pharmaceuticals
IRWD
IRWD
190 hedge funds and large institutions have $1.55B invested in Ironwood Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 67 increasing their positions, 65 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
6% less funds holding
Funds holding: 202 → 190 (-12)
16% less capital invested
Capital invested by funds: $1.84B → $1.55B (-$293M)
33% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 36
Holders
190
Holding in Top 10
2
Calls
$12.2M
Puts
$5.81M
Top Buyers
| 1 | +$13.5M | |
| 2 | +$11.7M | |
| 3 | +$10.4M | |
| 4 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
+$8.08M |
| 5 |
BM
Bridger Management
New York
|
+$7.67M |
Top Sellers
| 1 | -$27.2M | |
| 2 | -$26.9M | |
| 3 | -$15.6M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$15.2M |
| 5 |
BNP Paribas Asset Management
Paris,
France
|
-$13.1M |